D. BENJAMIN BORSON, M.A.,
J.D., Ph.D.
CURRICULUM VITAE
10 December 2018
DISCLAIMER
The information
contained in this Curriculum Vitae is for informational purposes only, and does
not imply or guarantee that any future or current legal representation will
produce similar results.
EXECUTIVE EXPERIENCE
Founder and President, Borson Law Group, PC, Intellectual Property Law Practice
Adjunct Professor of Law,
Past Member, Patent Public Advisory Committee, USPTO
Past Board Member and Past Chair, Business Law Corporate Counsel
Section,
Contra Costa County
Bar Association
Chair, Legislation Interest Group, IP Law Section, State Bar of
California
Co-Chair, Hot Topics Subcommittee, AIPLA
Co-Chair, Patent Policy Subcommittee, AIPLA
Co-Chair, Patent Law Subcommittee on Patentability, AIPLA
Past President, current Vice President and Board Member, Amphion Music Club
President and Board Member, Contra Costa Performing Arts Society
Past Member, New Zealand Biotechnology Organization
Past member of the Executive Committee, Intellectual Property Law
Section, State Bar of California;
member of IP and International Law Sections
Past Co-Chair, Council of State Bar Sections
Founder and Past President, BioScience Forum
Past Chair, Northern California Pharmaceutical Discussion Group
Past Principal Investigator, NIH Grant-Funded research program in basic
biomedical research
Past President, Buchanan Flying Club
Past President, Bay Flute Club
LEGAL EXPERIENCE
Intellectual Property. Develop and
implement business-focused
Scientific
Consultation: Experimental design and
implementation; evaluation of methods and results. Medical therapy and therapeutic standards in
physiology, pharmaceuticals, molecular diagnostics and genetic markers of
disease.
Patent
Drafting: Drafting and filing
provisional and utility patent applications, PCT and non-PCT foreign patent
applications. Drafting patents relating to therapeutics including antisense,
immunology, analytical methods, pharmaceuticals, bioinformatics, chemicals,
medical devices, medical and semiconductor polymers, manufacturing processes,
methods of use, semiconductor processing equipment for polymer deposition and
manufacture, organic and inorganic chemistry, superconductors, information
technology and software, oncogenes, nucleic acids, oncogene products; methods
of use: immunoassays, antisense and antibody therapy, diagnostic methods,
mechanical inventions, consolidation of applications and claim drafting.
Patent
Prosecution: Biotechnology, chemical, pharmaceutical,
bioinformatics, software, medical device, immunological, mechanical,
superconductivity and semiconductor patent prosecution: drafting amendments
relating to cellular uptake, efficacy of antisense nucleotide therapeutics,
bio-polymer chemistry, semiconductors, medical chemistry. Preparation of Information Disclosure
Statements. Drafting declarations and
petitions supporting patentability. Drafting Opposition documents for foreign
prosecution. Consultation with foreign
associates. Over 140 patents issued
Legal Opinions:
Research and preparation of legal opinions regarding joint ventures,
non-infringement and invalidity; due diligence analysis of patent applications,
patents and patent portfolios.
Contracts and Licensing: Negotiate and draft purchase and resale agreements,
confidentiality agreements, employee agreements, consulting agreements,
technology transfer and licensing agreements.
Evaluation of technical and legal services and due diligence. Over 50 Licenses and Agreements and 12
validity or non-infringement opinions prepared.
Trademarks:
Drafting, prosecution, and maintenance of trademark and service mark
applications and registrations in
Dispute
Resolution: Legal research and
analysis, preparing motions and memoranda of points and authorities, filing
court documents, court appearances, mediation and arbitration; draft cease and
desist letters.
Client
Development: Develop life sciences
and high-technology practice. Meet with
prospective clients, discuss intellectual property strategies and services,
develop and implement intellectual property strategies. Portfolio of current clients includes
immunology, bioinformatics, oncology, superconductors, pharmaceuticals,
diagnostics, phototherapy, molecular diagnostics and assay development.
Public
Service: Develop and present lectures
on Legal, Business and Scientific matters for
Training
Associates and Staff Supervise attorneys. staff and interns in
drafting and prosecution of patent applications, trademarks and trade secrets
world-wide, patentability and infringement opinions, firm practices and USPTO
practices.
Community
Service Perform musical works for non-profit organizations;
organize and develop programming for non-profit musical organizations.
REPRESENTATIVE CLIENTS
Company Technology
Acacia Patent Acquisition, LLC Biotechnology
Advanced Microdevices Semiconductor
Manufacturing and Chemistry
Advanced Technology & Materials, Inc. Chemistry, Nanotechnology, Advanced
Materials and
Semiconductor
Manufacturing
AIST-NT, Inc. Atomic
Force Microscopy
Alpha Golf, Inc. Medical
Devices, Systems Engineering and Therapeutics
Apollo Future Technology, Inc. Trademarks
Array Bioscience Corporation Chemistry, Nanotechnology and Instrumentation
Attend Systems LLC Data
Center Equipment Management Systems
Biophysica, Inc. Organic
Chemistry and Pharmaceuticals
Canon USA, Inc. Advanced
Materials, Semiconductor Manufacturing and
Tools
Design
Cellular Technology Limited Biotechnology and Diagnostic Instrumentation
DNP Pharmaceuticals Biotechnology
and Nucleic Acid Therapeutics
Fisher and Associates Medical
Diagnosis and Treatment
Fitzsimmons & Associates Ergonomics
FzioMed Inc. Biotechnology;
Medical Devices
Immune Solutions Ltd. Vaccines
MSM Protein Technologies Immunology, Antibody Therapeutics
Neuren Pharmaceuticals Limited Biotechnology, Chemistry and Pharmaceuticals
Otago Innovation Ltd. Molecular
Biology, Pharmaceuticals
Pacific Edge Ltd. Genetic Testing,
Diagnostics, and Bioinformatics Bioinformatics
Perseis Ltd. Antibody Therapeutics
and Diagnostics
Photomed Technologies, Inc. Medical Devices and Therapeutics
Powell, M. Chemotherapeutics
PrognosDx Molecular
Diagnosis and Prognosis
Quantum Polymer Corporation Chemistry, Nanotechnology and Advanced Materials
Rossi, T. Agriculture
RPK Pharmaceuticals, Inc. Trademarks
Salesforce.com Information
Technology
Simpson Strong-Tie Company Construction
Suncrest, USA Inc. Hydroponic
Agriculture
Tolmei, R. Mechanical
Engineering
True Light Technologies, Inc. Audiovisual Software
University of California Peptide Therapeutics
EMPLOYMENT IN THE LAW
2014 Member, Committee on Professional
Responsibility and Conduct, State Bar of California.
2010- Adjunct Professor of Law, Golden Gate University School of Law
2009-2012 Member, Patent Public Advisory Committee,
United States Patent and Trademark Office
2006- Founder
and President, Borson Law Group, PC
2004 - 2006 Of Counsel: Fliesler Meyer LLP
(formerly
Fliesler, Dubb, Meyer & Lovejoy LLP)
2003 Of
Counsel: Fliesler, Dubb, Meyer &
Lovejoy LLP
1997 - 2003 Associate: Fliesler, Dubb, Meyer & Lovejoy LLP:
1996 - 1997 Law Offices of Leona L. Lauder:
Biotechnology patent prosecution
1996 Philip
A. Dalton & Associates: Mechanical patent preparation
1994
Lecturer: Uses of DNA Technology in Forensic
Sciences.
Polymerase chain reaction, restriction fragment length
polymorphism, statistical analysis.
1993 Flehr, Hohbach, Test, Albritton,
& Herbert, San Francisco, California Summer Associate:
Biotechnology patent prosecution: drafting amendments pertaining to nucleic acids and
proteins; methods of use including antisense therapy, diagnostic methods
including immunoassays.
Litigation support: legal research and drafting: joinder, infringement, licensing. Patent
portfolio evaluation. Gene therapy,
nucleic acid delivery.
Scientific consultation protein synthesis, cellular uptake of therapeutic agents.
1987 - 1992 University
of
Experimental design: implementation of scientific support for patent applications. Biotechnology patent prosecution: drafting
disclosure documents and patent applications, declarations, and
amendments relating to Therapeutic Uses and Composition and Matter of
Enkephalinase.
LEGAL CERTIFICATION
State
Bar of
Registered
to Practice before the
EDUCATION
University
of
PROFESSIONAL ORGANIZATIONS
BioScience Forum (Founder and Past President)
Past Member,
Patent Public Advisory Committee (PPAC), USPTO (2009-2012)
State
Bar of
Committee
on Professional Responsibility and Conduct (COPRAC; 2013-
2014)
Professional
Liability Insurance Availability and Affordability Working
Group
Council
of Sections Advisor (2005-2006)
Council
of Sections (Co-Chair 2004-2005)
Council
of Sections (Co-Vice Chair 2003-2004)
Intellectual
Property Section
Legislation
Interest Group (Chair 2006-)
Council
of State Bar Sections IP Representative (2004-2006)
Executive
Committee (2001-2004)
Patent
Standing Committee (1999- )
Special
Commission on Proposed USPTO Rules (Chair)
Board
of Governor’s Task Force on Sections (Section Representative
2004-2006)
IP
Section Delegate, Conference of California Bar Associations (2007-
2010)
Am. Intel. Prop. Law Assoc. Biotechnology,
International law and Patent Committees,
Co-Chair,
Hot Topics Subcommittee (2016- )
Co-Chair,
Patent Policy Subcommittee (2014-2016)
Co-Chair,
Patentability Subcommittee (2011-2014)
Co-Chair,
Patent Subcommittee on Section 101 (2009-2011).
Contra
Costa County Bar Association, Chair, Business Law Corporate Counsel
Section
(2011-2013), Treasurer (2014-2016)
Federal
Circuit Bar Association (past)
Federated
Association of Societies for Experimental Biology (past)
American
Lung Association (past)
American
Physiology Society (past)
American
Association of Cell Biologists (past)
American
Chemical Society (past)
American Association of Pharmaceutical Scientists
(past)
PROFESSIONAL DEVELOPMENT
Originated
and maintained legal practice relating to life sciences, chemistry,
semiconductor manufacturing, copyright, IP counseling and IP transactions, in pharmaceuticals,
analytical instrumentation, biotechnology, genetics, information technology,
bioinformatics, immunology, diagnostics, therapeutics, superconductive
materials and semiconductor processing.
PATENTS PREPARED, PROSECUTED
1. Jui H.
Wang et al., Poly-Substituted-Phenyl-Oligoribonucleotides Having Enhanced
Stability and Membrane Permeability and Methods of Use, U.S. Pat. No:
5,858,988, issued Jan 12, 1999.
2. Herbert
E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide
Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing
Surgical Adhesions. U.S. Pat. No: 5,906,997, issued
3. Radu
Barsan et al., Use of Borophosphorous Tetraethyl Orthosilicate (BPTEOS) to
Improve Isolation in a Transistor Array.
4. James
E. Currie et al., Planarization Composition for Removing Metal Films. U.S. Pat. No: 5,993,685, issued
5. Ashraf
R. Khan et al., Surface Modification of Semiconductors Using Electromagnetic
Radiation. U.S. Pat. No: 6,015,759,
issued
6. Herbert
E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide
Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing
Surgical Adhesions. U.S. Pat. No:
6,017,301, issued
7. Chung
J. Lee et al., Precursors for Making Low Dielectric Constant Materials with
Improved Thermal Stability. U.S. Pat. No: 6,020,458, issued
8. Herbert
E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide
Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing
Surgical Adhesions. U.S. Pat. No:
6,034,140, issued
9. Giovanni
Antonio Foggiato et al., Large Area Discharge Excitation Radiator. U.S. Pat. No: 6,049,086, issued
10. Chung
J. Lee et al., Low Dielectric Constant Materials and Method. U.S. Pat.
No: 6,051,321, issued
11. Sunil
D. Mehta et al., Annealing of Silicon Oxynitride and Silicon Nitride Films to
Eliminate High Temperature Charge Loss.
U.S. Pat. No: 6,071,784, issued
12. David
Leksell et al., Chamber for Reducing Contamination During Chemical Vapor
Deposition.. U.S. Pat. No:
6,079,353, issued
13. Chung
J. Lee et al., Deposition Systems and Processes for Transport Polymerization
and Chemical Vapor Deposition. U.S.
Pat. No: 6,086,679, issued
14. Gouxi
Pan, High Hardness and Wear-Resistant Flux Cored Wire. U.S. Pat. No: 6,103,997, issued
15. David
Leksell et al., Chamber for Reducing Contamination During Chemical Vapor
Deposition. U.S. Pat. No: 6,114,227,
issued
16. Herbert
E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide
Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing
Surgical Adhesions. U.S. Pat. No: 6,133,325, issued
17. Chung
J. Lee et al., Chemicals and Methods for Making Fluorinated
Poly(Para-Xylylenes). U.S. Pat. No:
6,140,456, issued
18. Yue-Song
He et al., Barrier Layer Decreases
Nitrogen Contamination of Peripheral Gate Regions During Tunnel Oxide
Nitridation. U.S. Pat. No:
6,143,608, issued
19. Zoran
Krivokapic, Convex Device with Selectively Doped Channel. U.S. Pat. No: 6,153,454, issued
20. William Oppelt, et al., Laparoscopic Insertion and
Deployment Device, U.S. Pat. No:
6,193,731, issued
21. Lu You
et al., Cure Process for Manufacture of Low Dielectric Constant Interlevel
Dielectric Layers. U.S. Pat. No:
6,200,913, issued
22. Jonathan
Lin et al., Improving Field Leakage by Using a Thin Layer of Nitride
Deposited by Chemical Vapor Deposition.
U.S. Pat. No: 6,211,022, issued
23. Lu You et al., Rapid Acceleration Methods for Global
Planarization of Spin-On Films. U.S.
Pat. No: 6,225,240, issued
24 Effiong Ibok, Graded Anti-Reflective Barrier Films for Ultra-Fine Lithography
U.S. Pat. No: 6,235,456, issued
25. Chung
J. Lee et al., Precursors for Making Low Dielectric Constant Materials with
Improved Thermal Stability. U.S.
Pat. No. 6,258,407 B1, issued
26. James
E. Currie et al., Planarization Compositions for Removing Metal Films. U.S. Pat. No. 6,267,909, issued
27. Jui H.
Wang. Antiviral Anticancer
Poly-Substituted Phenyl Derivatized Oligoribonucleotides and Methods for Their
Use. U.S. Pat. No. 6,291,438, issued
28. Hyeon-Seag
Kim et al., Process for Manufacturing Shallow Trenches Filled With
Dielectric Material Having Low Mechanical Stress. U.S. Pat. No: 6,297,128, issued
29. Seshu
B. Desu et al., Near-Room Temperature Thermal Chemical Vapor Deposition of
Oxide Films, U.S. Pat. No: 6,316,055, issued
30. Lu You
et al., Apparatus and Methods for Uniform Scan Dispensing of Spin on
Materials. U.S. Pat. No: 6,317,642,
issued
31. David
Greenlaw et al., Process to Separate the Doping of Polygate and Source Drain
Regions in Dual Gate Field Effect Transistors. U.S. Pat. No: 6,319,804, issued
32. Richard
Brewer, Thomas J. Grebinski, James E. Currie, Michael Jones, William Muller,
and Ann Nguyen, Planarization
Compositions and methods for Removing Interlayer Dielectric Films, U.S.
Patent No. 6,122,600, issued November 27, 2001.
33. Chung
J. Lee et al., Low Dielectric Constant Materials with Improved Thermal and
Mechanical Properties. U.S. Pat. No:
6,323,297, issued
34. Seshu
B. Desu et al., Oxide/Organic Polymer Multilayer Thin Films Deposited by
Chemical Vapor Deposition. U.S. Pat. No: 6,358,863 B1, issued
35. Lu You et al., Solution Flow-In for
Uniform Deposition of Spin-on Films.
U.S. Pat. No: 6,387,825, issued
36. Lu You
et al., Methods of Manufacture of Uniform Spin-On Films. U.S. Pat. No: 6,407,009, issued
37. Hyeon-Seag Kim, Gate Insulator Process
for Nanometer Mosfets. U.S. Pat.
No: 6,413,826, issued
38. Effiong Ibok, Method for Fabricating High Permitivity
Dielectric Stacks Having Low Buffer Oxide.
U.S. Pat. No: 6,417,041, issued
39. Heyon-Seag Kim et al., Process for Manufacturing Shallow Trenches
Filled With Dielectric Material Having Low Mechanical Stress. U.S. Pat. No:
6,455,912, issued
40. Desu et al., Near-Room Temperature
41. Lu You et al., Closed Deposition Apparatus and Methods for
Regulating Drying of Spin-On Films.
U.S. Pat. No: 6,530,340 B2, issued
42. Chung J. Lee et al., Precursors for Making Low Dielectric
Constant Materials With Improved Thermal Stability. U.S. Pat. No: 6,534,616, issued
43. Raisa V. Talroze and Leonid N. Grigorov, Conductive Polymer
Materials and Methods for Their Manufacture and Use, U.S. Pat. No:
6,563,132, issued
44. Mark E.
Miller et al., Polyacid/Polyalkylene Oxide Foams and Gels and Methods for
Their Delivery, U.S. Pat. No: 6,566,345 B2, issued
45. Peter
D. Gluckman et al., Regulation of Tyrosine Hydroxylase. U.S. Pat. No:
6,617,311 B1, issued
46. Chung
J. Lee et al., Low Dielectric Constant Materials Prepared From Photon or
Plasma Assisted Chemical Vapor Deposition and Transport Polymerization of
Selected Compounds. U.S. Pat. No:
6,663,973, issued
47. Tajrena
Alexi, Methods for Promoting Weight Gain Using GPE-Related Compounds. U.S. Pat. No: 6,682,753 B2, issued
48. David
I. Kreimer et al., Systems and Methods for Filter Based Spectrographic
Analysis. U.S. Pat. No: 6,707,548,
issued
49.
50. Peter Gluckman et al., Use of GPE to Protect Glial Cells or
Non-Dopaminergic Cells From Death From Neural Injury of Disease. U.S. Pat.
No: 6,780,848, issued
51. Peter Gluckman et al., Methods to Improve Neural Outcome. U.S. Pat. No: 6,812,208, issued
52.
53. Raisa Talroze et al., Conductive Polymer Materials and
Methods for their Manufacture and Use,
U.S. Pat. No: 6,844,567, issued
54. Lance Hunter, Shaving Cream Dispenser. U.S. Pat. No: 6,860,413, issued
55. Herbert Schwartz et al., Compositions of Polyacids and
Polyethers and Methods for Their Use in Reducing Adhesions. U.S. Pat. No: 6,869,938, issued
56. Allan Gardiner et al., Illuminator with Filter Array and
Bandwidth Controller. U.S. Pat. No:
6,886,964, issued
57. Lin-Shu Lin et al., Chemically Activated
Carboxypolysaccharides and Methods for Use to Inhibit Adhesion Formation and
Promote Hemostasis. U.S. Pat. No: 6,923,961,
issued
58. Christopher Williams, Processing EEG Signals to Predict
Brain Damage. U.S. Pat. 6,931,274,
issued
59. Mark Vickers et al., Treatment of Hypertension Using Growth
Hormone in Mammals Subjected to Fetal Programming. U.S. Pat. No: 6,933,278, issued
60. Peter Gluckman et al., Regulation of Tyrosine Hydroxylase
by GPE. U.S. Pat. No: 6,933,282,
issued
61. Leonid Grigorov et al., Quantum Devices Based on
Crystallized Electron Pairs and Methods for Their Manufacture and Use. U.S. Pat. No: 7,014,795, issued
62. Norman Abood et al., GPE Analogs and Peptidomimetics,
U.S. Pat. No: 7,041,214, issued
63. William
Oppelt et al., Hemostatic Compositions of Polyacids and Polyalkylene Oxides
and Methods for Their Use.
Australian Patent No: 2001255716.
64. Peter Gluckman et al., GPE Analogs. U.S.
Pat. No: 7,112,570, issued
65. Chung Lee et al., Precursors for Making Low Dielectric Constant
Materials With Improved Thermal Stability.
Korean Patent No: 602222, registered
66. Chung Lee et al., New Deposition Systems and Processes for
Transport Polymerization and Chemical Vapor Deposition. Korean Patent No: 621226, registered
67. Constance Haber et al., Therapeutic Methods Using
Electromagnetic Radiation. U.S. Pat.
No: 7,150,710, issued
68. Geoffrey Krissansen et al., Treatment of Demyelinating
Diseases. U.S. Pat. No: 7,192,931,
issued
69. Richard Berg et al., Compositions of Polyacids and
Polyethers and Methods for Their Use as Dermal Fillers. U.S. Pat. No: 7,192,984, issued
70. Mark Miller et al., Polyacid/Polyalkylene Oxide Gels and
Methods for Their Delivery, U.S. Pat. No; 7,265,098, issued
71. David Batchelor et al., Methods for Detecting Weakly
Immunogenic Analytes. U.S. Pat. No:
7,282,432, issued
72. Michael Powell, Diagnosis and Treatment of Human Dormancy
Syndrome, U.S. Pat. No: 7,288,257,
issued
73. Arjen Scheepens et al., Neuroprotective Effect of Growth
Hormone. U.S. Pat. No: 7,304,029,
issued
74. Angel DeCegama, Methods for Real-Time Software Video/Audio
Compression, Transmission, Decompression and Display. U.S. Pat. No: 7,317,840, issued
75. Anthony Reeve et al., Medical Applications of Adaptive
Learning Systems Using Gene Expression Data. U.S. Pat. No: 7,370,021, issued
76. Seiya Imoto et al., Biological
Discovery Using Gene Regulatory Networks Generated from Multiple-Disruption
Expression Libraries. U.S. Pat. No. 7,430,475, issued
77. Michael Powell. Diagnosis and Treatment of Human
Dormancy-Related Sequellae, U.S. Pat. No: 7,485,298, issued
78. Paul William Richard Harris et al., Neuroprotective
Macrocyclic Compounds and Methods for Their Use, U.S. Pat. No: 7,485,630,
issued
79. Ron Tolmei, Activation
of Remote Control Transmitter Functions by External Inputs. U.S. Pat. No:
7,535,401, issued
80. Norman A. Abood and Margaret Anne Brimble, GPE Analogs and Petpidomimetics,
European Patent No: EP 1 401 808 B1, granted 8 July 2009.
81. Frank Sieg, Edmund Hughes, Thorsten Gorba, Neural Regeneration Peptides and Methods for
Their Use in Treatment of Brain Damage, U.S. Pat. No: 7,563,862, issued
82. Paul V. Lehmann, Alexey Y. Karulin, and Thomas Oliver Kleen, Nanoparticle and Microparticle Based
Detection of Cellular Products. U.S.
Pat. No: 7,598,093, issued
83. Peter David Gluckman, Gregory Brian Thomas, Jian Guan, Michael
Dragunov, Ashmit Kumar Anand, Frank Sieg, and Margaret Anne Brimble, Effects of Glyucyl-2 Methyl-Prolyl Glutamate
on Neurodegeneration. U.S. Pat. No:
7,605,177, issued
84. Frank Sieg, Edmund Hughes, Thorsten Gorba, Neural Regeneration Peptides and Methods for
Their Use in Treatment of Brain Damage, Japanese Patent No: 4,399,260,
issued
85. Frank Sieg et al. Neural Regeneration Peptides and Methods
for Their Use in Treatment of Brain Damage.
Japanese Patent No. 4,399,260, issued
86. Michael Powell, Diagnosis
and Treatment of Human Dormancy Syndrome, U.S. Pat. No: 7, 648,704, issued
87. Ron Tolmei, Means,
Methods, and Apparatus to Reduce the Possibility of a Motor Vehicle Entering a
Freeway Ramp in the Wrong Direction of Travel, Towards Oncoming Traffic,. U.S.
Pat. No: 7,650,236, issued
88. Peter David Gluckman, Margaret Anne Brimble, Douglas Wilson,
Frank Casper Tortella, Anthony Joseph Williams, Xi-Chun May, Jed. A. Hartings
and Devina Gryder, Treatment of
Non-Convulsive Seizures in Brain Injury Using G-2-Metheyl-Prolyl-Glutamate,
U.S. Pat. No: 7,714,020, issued
89. Allan Gardiner and Brent Michael McCullough, Systems and Methods for Displaying Changes
in Biological Reponses to Therapy, U.S. Pat. No: 7,720,306, issued
90. Frank Ernest Aldwell, Bryce Malcolm Buddle, and Ian George
Tucker, Antigenic Compositions, U.S.
Pat. No: 7,758,869, issued
91. Frank Sieg et al. Neural Regeneration Peptides and Methods
for Their Use in Treatment of Brain Damage.
U.S. Pat. No. 7,776,786, issued
92. Au-Yeung Kwok-Leung and Lee B. Bussey. Apparatus and Methods for Preparative Scale Purification of Nucleic
Acids, U.S. Pat. No. 7,771,945, issued
93. Margaret Anne Brimble and Jian Guan, Cyclic G-2AllylProline in Treatment of Parkinson’s Disease, U.S..
Pat. No. 7,776,876, issued August 17, 2010.
94. Robert Bridenbaugh, Warren Dang, and Lee B. Bussey, Methods for Purifying Nucleic Acids. U.S. Pat. No. 7,807,822, issued
95. Margaret Anne Brimble, Paul William Harris, and Frank Sieg, Analogs of Glycyl-Prolyl-Glutamate, U.S.
Pat. No. 7,863,304, issued
96. Constance Haber and Allan Gardiner, Therapeutic Methods Using Electromagnetic Radiation,
97. Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral Formulations of Glycyl-2-Methyl
98. Constance Haber and Allan Gardiner, Therapeutic Methods Using Electromagnetic Radiation,
99. Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert
Rosenberg, Anthony Edmund Reeve, Michael Alan Black, Johan Lindsay McCall,
Yu-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal
Cancer, Singapore Patent No. 143,707, granted 29 April 2011.
100. Ron Tolmei, Visual
Indicator for Electrosurgical Instrument Fields, U.S. Pat. No. 7,963,957,
issued June 21, 2011.
101. Paul William Richard Harris and Margaret Anne Brimble, Neuroprotective Macrocyclic Compounds and
Methods for Their Use, U.S. Pat. No. 8,013,170, Issued September 6, 2011.
102. Frank Ernest Aldwell, Bryce Malcolm Buddle and Ian George
Tucker, Antigenic Compositions,
Chinese Patent No. ZL 02817408.9, Issued 7 September 2011.
103. Angel DeCegama, Systems
and Methods for Compression,Transmission and Decompression of Video Codecs,
U.S. Pat. No. 8,031,782, issued October 4, 2011.
104. Margaret Anne Brimble et al., Neuroprotective Bicyclic Compounds and Methods for Their Use,
Japanese Patent No. 4842817, granted 14 October 2011.
105. Margaret Brimble, Jian Guan, Frank Sieg, Neuroprotective Bicyclic Compounds and Methods for Their Use, U.S.
Pat. No.8,067,425, issued November 29, 2011.
106. Michael Powell. Diagnosis and Treatment of Cancer Related to
Human Dormancy, U.S. Pat. No. 8.075,902, issued December 13, 2011.
107. Ron Tolmei. Centre High
Mount Stop Lamp with Constituent Seatbelt Disengagement Indicator, U.S.
Pat. No. 8.081,068, issued
108. Paul V. Lehmann, Alexey V. Karulin, and Thomas Oliver Kleen, Nanoparticle and Microparticle Based
Detection of Cellular Products, U.S. Pat. No. 8,088,630, issued
109. Tim Zapalski, Apparatus
and Method for Generating and Tracing Vortices, U.S. Pat. No. 8,146,893,
issued
110. Kwok-Leung Au-Yeung and Lee Bussey, Apparatus and Method for Preparative Scale Purification of Nucleic
Acids, U.S. Pat. No. 8,158, 348, Issued
111. Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral Formulations of Glycyl-2-Methyl
112. Samuel Nochumson, Ross Durland, Audrey Yu-Speight, John Welp,
Kouwei Wu, and Rexford Hayes, Process and
Equipment for Plasmid Purification, U.S. Pat. No. 8,236,495, issued August
7, 2012.
113. Noah Groth, Jan P. Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Equipment Locator and Monitoring
System, U.S. Pat. No. 8,264,354, issued September 11, 2012.
114. Quentin Lewis Hibben, Low
Temperature Curable Adhesive Compositions, U.S. Pat. No. 8,334,346, Issued
December 18, 2012.
115. Allan Gardiner and Tai Huynh, Therapeutic Methods Using Electromagnetic Radiation, U.S. Pat. No.
8,343,026, Issued January 1, 2013.
116. Michael Powell, Diagnosis
and Treatment of Human Dormancy Related Sequellae, U.S. Pat. No. 8,343,485,
Issued January 1, 2013.
117. Leonid Grigorov, Methods
and Devices for Programmable Delivery of Microdoses of Liquid Drugs and Other
Fluids, U.S. Pat No. 8,435,212, Issued May 7, 2013.
118. Frank Aldwell, Bryce Malcolm Buddle, and Ian George Tucker, Antigenic Compositions. Canadian Patent No. 2,454,920, Granted 25
June 2013.
119. Jingyuan Wen, Gregory Brian Thomas, and Mike John Bickerdike, Oral Formulations of
Glycyl-2-Methylprolyl-Glutamate, U.S. Patent No. 8,496,963, Issued July 30,
2013.
120. Angel DeCegama, Systems
and Methods for Compression, Transmission and Decompression of Video Codecs,
U.S. Patent No. 8,503,543, Issued August 6, 2013.
121. Joseph A. Mendoza, Remote
Key Device, U.S. Patent No. 8,511,122, Issued August 20, 2013.
122. Mike John Bickerdike, Margaret Anne Brimble, and Ernest Stephen
Siritmanne, Cyclic-Glycyl-2-Allyl Proline
and Its Use in Treatment of Peripheral Neuropathy, U.S. Patent No.
8,519,127, issued August 27, 2013
123. Ashraf R. Khan, Sasangan Ramanathan, and Giovanni Antonio
Foggiato, Surface Modification of
Semiconductors Using Electromagnetic Radiation, European Patent No.
1,038,307, granted 11 September 2013.
124. Peter David Gluckman, Jian Guan, Mary-Anne Woodnorth, and
Margaret Anne Brimble, Method for
Cognitive Enhancement and Cognitive Therapy Using Glycyl-2-Methyl Prolyl
Glutamate. U.S. Patent No. 8,637,
567, issued January 28, 2014.
125. Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert
Rosenberg, Anthony Edjund Reeve, Michael Alan Black, John Lindsay McCall,
Yu-Hsiu Lin, and Robert Craig Pollock, Prognosis
Prediction for Colorectal Cancer, Hong Kong Patent No. HK1127125, granted
28 February 2014.
126. Robert Bridenbaugh, Warren Dang, and Lee Bussey, Methods for Purifying Nucleic Acids,
U.S. Patent No. 8,680,261, issued March 25, 2014.
127. Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral Formulations of
Glycyl-2-Methylprolyl-Glutamate, European Patent No. EP 2 001 400 B1,
granted 7 May 2014.
128. Noah Groth, Jan P. Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Server Location and Monitoring
System, U.S. Patent No. 8,779,922,
issued July 15, 2014.
129. Michael John Bickerdike
and Jian Guan, Cyclic
Glycyl-2-AllylProline Improves Cognitive Performance in Impaired Animals,
U.S. Patent No. 8,791,117, issued July 29, 2014.
130. Michael Alan Black, Jonathan Cebon, Parry John Guilford, and
Thomas John, Prognosis Prediction for Melanoma
Cancer, U.S. Patent No. 8,822,149, issued September 2, 2014.
131. Hjalmar
Nekareda, Jan Frederichs, Bernard Holzmann, Robert Rosenberg, Anthony Edmund
Reeve, Michael Alan Black, John Lindsay McCall, Y-Hsin Lin, and Robert Craig
Pollock, Prognosis Prediction for Melanoma Cancer, Japanese Patent No.
5632581, granted October 17, 2014.
132. Leonid Grigorov, Methods
and Devices for Programmable Delivery of Microdoses of Liquid Drugs, U.S.
Patent No. 8,876,802, issued November 4, 2014.
133. Samuel Falcone and Richard Berg, Carboxymethylcellulose
Polyethylene Glycol Compositions for Medical Uses, Australian Patent No.
2008-330166, granted 8 January 2015.
134. Noah Groth, Jan Warhuus, and Krassimir
Anastassov Boyadjiev, Data Center
Equipment Location and Monitoring System, U.S. Patent No. 8,994,532, issued
March 31, 2015.
135. Hjalmar Nekareda, Jan Frederichs, Bernard
Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John
Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer, Korean Patent No.
10-1530689, granted 16 June 2015.
136. Paul V. Lehmann, Multivalent Opsonophagocytic Assay Using Bead Array and Imaging,
U.S. Patent No. 9,063,145, issued June 23, 2015.
137. Michael John Bickerdike and Jian Guan, Cycllic-Glycyl-2-AllylProline Improves
Cognitive Performance in Impaired Animals,
U.S. Patent No. 9,119,851, issued September 1, 2015.
138. Margaret Brimble, Jian Guan, and Frank
Sieg, Neuroprotective Bicyclic Compounds
and Pharmaceutical Compositions Containing Them, European Patent No. EP 1
664,050 B1, granted 12 September 2015.
139. Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol
Compositions for Medical Uses, U.S. Patent No. 9,161,987, issued October
20, 2015.
140. Hjalmar Nekarda, Jan Friederichs, Bernard
Holzmann, Robert Rosenberg, ANtony Edmund Reeve, Michael Alan Black, John
Lindsay McCall, Yu-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer. Korean Patent No. 10-1562644, Issued October
16, 2015.
141. Lawrence Irwin Glass, Michael John
Bickerdike, and Michael Frederich Snape, Treatment
of Rett Symdrome Using Glycyl-L-2-Methylprolyl-L-Glutamic Acid, U.S. Patent
No. 9,212,204, issued 15 December 2015.
142. Hjalmar Nekarda, Jan Friederichs, Bernhard
Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John
Lindsay McCall, Yu-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer, Korean Patent No.
10-1579934, granted 26 December 2015.
143. Alexandr A. Golub, Olga O. Billaieva,
Viacheslav v. Neshta, Antimicrobial
Compositions, U.S. Patent No. 9,302,027, issued April 5, 2016.
144. Parry John Guilford, Markers for Detection of Gastric Caner, U. S. Patent No. 9,310,370,
issued 12 April 2016.
145. Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol
Compositions for Medical Uses, U.S. Patent No. 9,345,809, issued 24 May
2016.
146. Larry Glass, Michael John Bickerdike, and
Michael Frederick Snape, Treatment of
Autism Spectrum Disorders Using Glycyl-L-2-methylprolyl-L-Glutamic Acid,
Australian Patent No. 2012209466, granted 16 June 2016.
147. Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol
Compositions for Medical Uses, U.S. Patent No. 9,381,271, issued 5 July
2016.
148. Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol
Compositions for Medical Uses, European Patent No. 2,211,907, granted 15
July 2016.
149. Nikola Kirilov Kassabov, Matthias Futschik,
Michael James Sullivan, and Anthony Edmund Reeve, Medical Decision Support Systems Utilizing Gene Expression and Clinical
Information, European Patent No. 1,534,122, granted 20 July 2016.
150. Hjalmar Nekarda, Jan Frederichs, Bernard
Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John
Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer. Japanese Patent No. 6,058,780, granted 16
December 2016.
151. Michael Alan Black, Jonathan Cebon, Parry
John Guilford, and Thomas John, Devices
and Methods for Prognosis Prediction for Melanoma Cancer, U.S. Patent No.
9,534,258, issued 3 January 2017.
152. Sergey Saunin, Andrey V. Krayev, Vladimir
V. Zhizhimontov, Vasily V. Gavrilyuk, Leonid N. Grigorov, Alexey V. Belyaev,
Dmitry Evplov, Systems and Methods for
Non-Destructive Surface Chemical Analysis of Samples, U.S. Patent No.
9,568,495, issued, 14 February 2017.
153. Samuel Falcone, Compositions of Carboxymethylcellulose and Polyethylene Oxide
Cross-Linked Using Polyhydroxyl Organic Anions. U.S. Patent No. 9,636,434, issued 2 May 2017.
154. Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose Polyethylene Glycol
Compositions for Medical Uses, U.S. Patent No. 9,682,167, issued 20 June
2017.
155. Parry John Guilford, Urine Gene Expression Ratios for Detection of Cancer, U.S. Patent
No. 9,702,009, issued 11 July 2017.
156. Timothy James Rossi, Method and System of Using Electromagnetism to Control Fertilizer
Leaching, U.S. Patent No. 9,707,568, issued 18 July 2017.
157. Lawrence Glass, Michael John Bickerdike,
and Michael Frederick Snape, Treatment of
Fragile X Syndrome Using Glycyl-L-2-Methylprolyl
Glutamic Acid, U.S. Patent No. 9,708,366, issued 18 July 2017.
159. Lawrence Irwin Glass, Michael John
Bickerdike, and Michael Frederick Snape, Treatment
of Autism Spectrum Disorders Using Glycyl-L-2-Methylprolyl Glutamic Acid,
EP Patent No. 2,667,715, granted 19 July 2017.
160. Nikola Kasabov, Adaptive Learning System and Method, EP Patent No. 1,287,488,
granted 4 October 2017.
161. Hjalmar Nekarda, Jan Frederichs, Bernard
Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John
Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Progonsis Prediction for Colorectal Cancer, Japanese Patent No.
6,218,141 , granted 6 October 2017.
162. James P. Day, Interlocking Raft for Deepwater Culture Hydroponics, U.S. Patent
No. 9,807,950, issued 7 November 2017.
163. Parry John Guilford. Test Kits and Methods for Their Use in Detecting Expression Ratios of
Genetic Markers, U.S. Patent No. 9,809,860, issued 7 November 2017.
164. Samuel J. Falcone, Compositions of Carboxypolysaccharides and Polyalkylene Oxides
Cross-Linked Using Polyhydroxyl Organic Anions, U.S. Patent No. 9,821,088,
issued 21 November 2017.
165. Lawrence Irwin Glass, Michael John
Bickerdike, Michael Frederick Snape, and Patricia Perez DeCogram, Neuroprotective Bicyclic Compounds and
Methods for Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental
Disorders. U.S. Patent No.
9,867,823, issued 16 January 2018.
166. Stephen Kilfeather, Alberto Taurozzi, Paul
Lehmann, and Elaine Lee. Immobilised-Bead Immunomultiplex Assay,
U.S. Patent No. 9,945,786, issued 17 April 2018.
167. Timothy James Rossi, Method and System of Using Electromagnetism to Control Fertilizer
Leaching, EP Patent No. 3,079,789, granted 18 April 2018.
168. Lawence Irwin Glass, Michael John
Bickerdike, and Michael Frederick Snape, Treatment
of Autism Spectrum Disorders Using Glycyl-2-Methylprolyl-L-Glutamic Acid,
Japanese Patent No. 6,342,459, granted May 25, 2018.
169. Parry John Guilford, Mark Dalphin, Laimonis
Kavalieris, and Paul O’Sullivan, Polymerase
Chain Reaction Test Kits for Detecting Markers for Bladder Cancer, U.S. Patent
No. 9,982,305, Issued 29 May 2018.
170. Sergey A. Saunin, Andrey V. Krayev,
Vladimir V. Zhishimontov; Vasily V. Gravrilyuk, Lenoid N. Grigorov, Alexey V.
Belyaev, and Dmitry Evplov, Systems and
Devices for Non-Destructive Surface Chemical Analysis of Samples, U.S.
Patent No. 9,989,566, Issued 5 June 2018.
171. Lawrence Irwin Glass, Michael John
Bickerdike, and Michael Frederick Snape, Treatment
of Autism Spectrum Disorders Using Glycyl-2-Methylprolyl-L-Glutamic Acid,
Japanese Patent No. 6,348,283, granted 8
June 2018.
172. Parry John Guilford, Markers for Detection of Gastric Cancer, U.S. Patent No. 10,024,859,
issued 17 July 2018.
173. Samuel J. Falcone, Compositions of
Carboxypolysaccharides and Polyethylene Oxides Cross-Linked Using Polyhydroxyl
Organic Anions, U.S. Patent No. 10,052,408, issued 21 August 2018.
174. John Fitzsimmons and Alexander Kuznetsov, Computer Assisted Egronomic Workstation
Designs and Methods, U.S. Patent No. 10,078,096, Issued 18 September 2018.
175. Stephen Kilfeather, Alberto Taurozzi, Paul
Lehmann, and Elaine Lee, Immobilised-Bead
Immunomultiplex Assay, EP Patent No. 2,536,818, Granted 3 October 2018.
176. Timothy James Rossi, Method and System of Using Electromagnetism to Control Fertilizer
Leaching, U.S. Patent No. 10,130,955, issued 20 November 2018.
177. David Darling, James Miller Suttie, Mark
Dalphin, Laimonis Kavalieris, Paul O’Sullivan, and Satish Kumar, Methods for Detecting Genetic and Phenotypic
Biomarkers of Urothelial Carcinoma and Treatment Thereof. U.S. Patent No. 10,131,955, issued 20
November 2018.
178. James P. Day, Interlocking Raft Segment for Deepwater Culture Hydroponics, U.S.
Patent No. 10,149,445, issued 11 December 2018.
TRADEMARK REGISTRATIONS
1. ELANTEC, U.S.
Reg. No. 2,566,377, Reg. Date: May 7, 2002.
2. IMMUNOSCAN, U.S.
Reg. No. 3,182,039, Reg. Date: December 5, 2006, Cellular Technology
Limited.
3. SPOTMAP, U.S.
Reg. No. 3,221,091. Reg. Date: March 27,
2007, Cellular Technology Limited
4. IMMUNOSPOT, U.S.
Reg. No. 3,438,787, Reg. Date: June 3, 2008, Cellular Technology Ltd.
5.
6. “Photomed Ribbon”
Misc. Design, Reg. No.3,468,580.
U.S. Reg. Date: July 15, 2008, Photomed
Technologies, Inc.
7. SIMPL, U.S. Reg.
No. 3,680,118, Reg. Date: September 8,
2009, MSM Protein Technologies, Inc.
8. OASIS, U.S. Reg.
No. 3,532,352. Reg. Date: November 11, 2008, Thomas Grebinski.
9. BIOSPOT, U.S.
Reg. No. 3,544,006, Reg. Date: December 9, 2008, Cellular Technology Ltd.
10. UVSPOT, U.S. Reg.
No. 3,602,913, Reg. Date: April 7, 2009, Cellular Technology Ltd.
11. PHOTOMED TECHNOLOGIES
(and Design), U.S. Reg. No.
3,612,813. Reg. Date: April 28, 2009,
Photomed Technologies, Inc.
12. EPBMC, U.S. Reg.
No. 3,753,512. Reg. Date: March 2, 2010,
Cellular Technology Ltd
13. LIPORALE,
AU Reg. No. 1359886, Reg. Date : 05 May 2010, Immune Solutions Ltd.
14.
15. TB SCAN, U.S. Reg.
No. 3,823,344, Reg. Date: July 30, 2010,
16. LIPORALE, CTM Reg.
No. 009080961, Reg. Date: 27 September 2010, Immune Solutions Ltd.
17. BIOSPOT, U.S. Reg.
No. 3,855,285, Reg. Date: October 5, 2010, Cellular Technology Limited.
18. LIPORALE, NZ Reg.
No. 823728, Reg. Date: 5 November 2010, Immune Solutions Ltd.
19. UVSPOT, U.S. Reg.
No. 3,871,787, Reg. Date November 9, 2010, Cellular Technology Limited.
20. IMMUNOSPOT, CTM
Reg. No. 006856769, Reg. Date 11 November 2010, Cellular Technology Limited:
21. EPBMC, CTM Reg. No.
009225178, Reg. Date 22 December 2010, Cellular Technology Ltd.
22. IMMUNOSPOT, U.S.
Reg. No. 3,909,607. Reg. Date: January
25, 2011, Cellular Technology Ltd:
23.
24.
25. CXBLADDER, U.S.
Reg. No. 4,188,826, Reg. Date: 14 August 2012.
26. APOLLO, U.S. Reg.
No. 4,574,930, Reg. Date: July 29, 2014, Apollo Future Technology, Inc.
27. MBDXA, U.S. Reg.
No. 4,585,240, Reg. Date: August 12, 2014, MSACL, Inc.
28. Miscellaneous Design
(Shore, River and Mountains), U.S. Reg. No. 4,608,560, Reg. Date: 23
September 2014.
29. PACIFIC EDGE, U.S.
Reg. No. 4,662,781, Reg. Date: 30 December 2014.
30. PACIFIC EDGE DIAGNOSTICS
USA LTD plus Design, U.S. Reg. No. 4,717,259, Reg. Date: April 7, 2015.
31. FA-Q, U.S. Reg. No.
4,831,000, Reg. Date: October 13, 2015.
32. WACKY JACKY, U.S.
Reg. No. 4,836,584, Reg. Date: October 20, 2015.
33. AMERICAN PIE, U.S.
Reg. No. 4,836,592, Reg. Date: October 20, 2015.
34. FAUXSTESS CUPCAKES,
U.S. Reg. No. 4,836,594, Reg. Date: October 20, 2015.
35. MISS SAMOA, U.S.
Reg. No. 4,836,599, Reg. Date: October 20, 2015.
36. SYNCRO-CLEANSE,
U.S. Registration No. 5,148,140, Reg. Date. February 21, 2016.
37. ERGONOMICS FIRST,
U.S. Reg. No. 4,973,720, Reg. Date: June 7, 2016
38. HIPTORQUE, U.S.
Reg. No. 5,975,051, Reg. Date: June 7, 2016.
39. LOPREST, U.S. Reg.
No. 5,089,887, Reg. Date: November 29, 2016.
40. SPOT STAT, U.S. Reg.
No. 5,360,832, Reg. date: December 19,
2017.
41. Miscellaneous Drawing
(“Stickman”), U.S. Reg. No. 5,510,715, Reg. Date: July 10, 2018.
42. TUBENMANN U. S.
Reg. No. 5,529,111, Reg. Date: July 31, 2018.
LEGAL PUBLICATIONS
Borson, D.B. Keep Your Genes Fresh with a CRISPR: Report on Interference
between
University of California v. Broad Institute, Inc., New
Matter, 43(4):8-12, 35, Winter
2018). Intellecutal Property Law
Section, California Lawyers
Association.
Borson, D.B. University of California v. Broad Institute, Inc. Biotech_Buzz,
(October 2018). Case Law Reviews
Subcommittee, Biotechnology
Committee, American Intellectual
Property Law Association.
Borson, D.B. Artificial Intelligence: S.2217, H.R. 4625 New Matter 43(3):12-17,
(Fall 2018), Intellectual
Property Law Section, California Lawyers
Association.
Borson, D.B. Highway [35. U.S.C. Section 101]: Finding the On Ramp,
New Matter, 43(2):11-14
(Summer 2018), Intellectual Property
Law Section, California Lawyers
Association.
Borson, D.B. Commentary: Do the Proposed Rulemaking Claim Construction
Standard
Changes Go Far Enough, New Matter, 43(2):29-30
(Summer 2018), Intellectual
Property Law Section, California
Lawyers Association.
Borson, D.B. Vanda Pharmaceuticals, Inc. v. West-Ward Pharmaceuticals
International,
West-Ward Pharmaceuticals Corp. Biotech_Buzz,
Case Law Reviews Subcommittee,
Biotechnology Committee,
AIPLA (13 April 2018).
Borson, D.B. S. 2217 and H.R. 4625 the “Fundamentally
Understanding The
Usability and Realistic Evolution of
Artificial Intelligence Act of
2017” or the
“FUTURE of Artificial Intelligence Act of 2017,”
and H.R. 4829, the “Artificial
Intelligence Job Opportunities and
Background
Summary Act of 2018 or the ‘AI JOBS Act of 2018,”
Report of the Legislation
Interest Group, Intellectual Property Law
Section, State Bar of California
(March 2018).
Borson, D.B. Patent Eligibility, Catch Me if You Can, MCLE Self-Study Article,
Intellectual Property Law Section,
California Lawyers Association
New Matter 43(1):10-14, 55
(Spring 2018).
Borson, D.B. Berkheimer v. HP, Biotech Buzz Case Law Review Subcommittee,
AIPLA
(February 2018).
Borson, D.B. Genzyme Corp. Sanofi-Aventis U.S., LLC v. Dr. Reddy’s
Laboratories
Ltd, Dr. Reddy’s Laboratories, Inc. and Teva
Pharmaceuticals, Biotech Buzz Case
Law Review Subcommittee,
Biotechnology Committee, AIPLA
(January 2018).
Borson, D.B. Supreme Court Decisions: Sandoz Inc. v. Amgen, Inc. et al.,
New Matter 42(3): 23-26,
43, Intellectual Property Law Section,
State Bar of California (Fall
2017).
Borson, D.B. & Report of the Legislation Interest Group
to the Intellectual
Mark Leonard. Property Law Section Executive Committee: S. 974 and
H.R. 2212 The “Creating and Restoring Equal Access To Equivalent Samples” Act
(“CREATES” Act) or “CREATES Act of 2017”
29
July 2017, State Bar of California.
Borson, D.B. & Federal
Legislation Update: Report of the
Legislation Interest
Mark Leonard
Group to the Intellectual
Property Law Section Executive
Committee (21 July 2017).
Borson, D.B. Short Comment on Section 101; New
Matter 42(1):13-14 (Spring
2017)
Borson, D.B. In re van Os et al., Biotech Buzz,
AIPLA Case Comment
Subcommittee (January 2017).
Borson, D.B. & Federal Legislation Update: new initiatives before the U.S. House
Mark Leonard of Representatives,
Report of the Legislation Interest Group to the
Intellectual Property Law Section
Executive Committee
Report
on 12 January 2017, State Bar of California.
Borson, D.B. Recent Federal Legislation, Trans Pacific
Partnership Agreement
and
Protect Trade Secrets Act, New Matter 41(2):28-33 (2016),
State
Bar of California Intellectual Property Law Section.
Borson, D.B. Genetic Technologies Limited v. Merial
L.L.C. Bristol-Meyers
Squibb Company, Biotech Buzz, Case
Law Review Subcommittee, AIPLA,
April 2016.
Borson, D.B. & Report of the Legislation Interest Group
to the Intellectual
Mark Leonard Property Law Section on the Trans Pacific Partnership
Agreement
and America Invents Act, State Bar of California,
19 March 2016.
Borson, D.B. & Report of the Legislation Interest Group
to the Intellectual
Mark
Leonard Property Law Section on the Trans Pacific Partnership
Agreement, State Bar of California,
12 January 2016.
Borson, D.B. & Report of the Legislation Interest Group
to the Intellectual
Mark Leonard Property Law Section,
State Bar of California, 2 November 2015.
Borson, D.B. Comments on July 2015 Guidance on Eligible
Subject Matter, 26
October
2015, http://www.uspto.gov/patent/laws-and-regulations/comments-public/comments-july-2015-update-subject-matter-eligibility.
Borson, D.B. The Medicines Company v. Hospira, Inc. Biotech
Buzz, Case Law
Review Subcommittee, AIPLA, August
21, 2015.
Borson, D.B. Legislation Update, New Matter
40(1):23-30 (Spring 2015).
Leonard, M.
Borson, D.B. Legislation Update, New Matter
39(4):19-20 (Winter 2014).
Leonard, M.
Borson, D.B. Case Summary of AbbVie v. Janssen, Biotech
Buzz Case Law
Review Subcommittee, AIPLA (16
July 2014).
Borson, D.B. Legislation Interest Group Report: Extract,
New Matter 39(1):61-
M. Leonard 62
(2014).
Schultz, A. & Report from the International Interest Group
on Changes in
Borson, D.B, Australian
Practice New Matter
39(1):47-48 (2014).
Borson, D.B. Comments on New USPTO Guidance for
Examination of
Applications
Including Laws of Nature, submitted to USPTO (29
April 2014).
Borson, D.B. Senju
v. Apotex, Biotech Buzz, AIPLA Biotech Committee,
(April
18, 2014).
Borson, D. B. Methods
Claims Must Recite Specific Steps Needed to Achieve
Results, Smartgene v.
Advanced Biological Labs.,
Biotech
Buzz, AIPLA Diagnostics & Gene Patenting
Subcommittee, February 24, 2014.
Craig, A.G & Addressing
Unfair Litigation Practices in Patent Law, New Matter
Borson, D.B. 38(4):19-23
(Winter 2013)
Borson, D.B. Sunovion
v. Teva and Dr. Reddy’s, Biotech Buzz, Case Law
Review Subcommittee, AIPLA, November 2013
Borson, D.B. Biogen
v. GSK, Biotech Buzz, Case Law Review Subcommittee, AIPLA. (April 16, 2013).
Borson, D.B. Annual
Report of the Patent Public Advisory Committee,
et al. November 2. 2012.
Borson, D.B. Avoiding
Disputes, Keep the Litigants Out of It. Business Law Corporate Counsel
Section, Contra Costa Lawyer, August 1, 2012.
Borson, D.B. The
Leahy-Smith America Invents Act of 2011: Section 3 of the
D. Eastham
Matteo D.C. Annual
Report of the Patent Public Advisory Committee,
et al. November
4, 2011)
Borson, D.B. The
Leahy-Smith America Invents Act of 2011: An Introduction.
D. Eastham New
Matter, 36(4): 5-24 (2011).
Matteo, D.C. Annual
Report of the Patent Public Advisory Committee,
et al. November 1, 2010.
Borson, D.B. Proposed
Legislation on Patent Reform and IP, New Matter 34(2):160-161
(2009).
Borson, D.B. Legislation
Committee Report of May 4, 2009, New Matter 34(2): 60-66 (2009).
Friedman Report of the Delegation of IP
Section of the State Bar of
et al. California to Washington
D.C., April 6, 2009, New Matter 34(2):48-52 (2009).
Borson, D.B. Legislation
Committee Report, New Matter 33(2):50-51 (2008).
Grunebach A
Town Focused on Change; IP Law Section’s 2008 Delegation to
et al., DC, New Matter 33(2):40-45 (2008).
Borson, D.B. Assisting
with U.S. Patent Prosecution and Preserving U.S. Patent Rights, In: U.S.
Patent Practice for Paralegals: HalfMoon LLC. pp:4-1 to 4-83 (2008).
Borson, D.B. Note
from the Legislation Committee, New Matter 32(4):4 (2007).
Borson, D.B. Report of the Legislation Committee: USPTO Final Rules on
Claims and
Continuations. New Matter 32(2):44-57
(2007).
Mendoza Annual
D.C. Trip Plays a Key Role in Maintaining Strong Federal
et al. Relationships, New Matter
32(2)34-39 (2007).
Borson, D.B. KSR v. Teleflex, Inc.: The Supreme
Court Reviews Obviousness. J. Patent and Trademark Office Society 89(7):523-544
(2007).
Borson, D.B. KSR v. Teleflex, Inc.: The
Supreme Court Reviews Obviousness. New
Matter 32(1):11-39 (2007).
Borson, D.B. LabCorp v. Metabolite: Legal
and Scientific Terminology: An Example of Poor Correlation. New Matter, 31(3):31-43 (2006).
Borson, D.B. Changes
to Practice for Continuing Applications Requests for
et al. Continued Examination
Practice and Applications Containing Patentably Indistinct Claims, Ad-Hoc Commission of California Attorneys, Comments
submitted to USPTO May 3, 2006.
Borson, D.B. Proposed Rules for Patent
Practice: Continuations and Claims. New
Matter 31(2): 16-20 (2006).
Borson, D.B. Comments
on Proposed Rules (37 C.F.R. Part 11), Ad-Hoc
et al., Committee of
Registered Patent Attorneys, Submitted to USPTO June 10, 2004.
Borson, D.B. Intellectual Property Strategies
in the Life Sciences: Introduction to Biotechnology Patents. IBC Life Sciences, Inc. (November
2003).
Borson, D.B. Current Status of U.S. Patent
Law. In: Intellectual Property Practice for Paralegals. Half Moon Seminars, LLC.
Borson, D.B Doctrine of Equivalents in Light
of the Supreme Court’s Decision
in
Festo: Law and Equity in Intellectual
Property. New
Matter 27(2/3): 9-10, 36-43, (2002).
Borson, D.B. Intellectual Property Protection
in High Technology Industries:
&S.R.Meyer: Trade Secrets, Patents, and Ethics. State Bar of California Convention,
September 7, 2001.
Borson, D.B. State Immunity from Federal
Patent and Trademark Laws, Part II.
New Matter, 26(1-2):5-10
(2001).
Borson, D.B. Protecting Inventions in
Combinatorial Chemistry
Cambridge Healthtech Institute Symposium
on Exploiting
Molecular
Diversity Refining Small Molecule Libraries (February
12-14,
2001).
Borson, D.B. State Immunity from Federal
Patent and Trademark Laws, Part I.
New Matter 25(2):3-6 (2000).
Borson, D.B. Patenting Inventions in
Combinatorial Chemistry, Journal of Molecular Graphics and Modeling
18(1):63-71 (2000).
Borson, D.B. Overview of Intellectual Property
Protection. In: Intellectual
Property
Practice for Paralegals. Half Moon
Seminars, LLC.
Eau Claire, WI, pp:I1-I4 (1998).
Borson, D.B. International Patent Practice. In: Intellectual Property Practice
for
Paralegals Half Moon Seminars, LLC.
V40
(1998).
Borson, D.B. The Human Genome Project:
Patenting Human Genes and
Biotechnology.
Is the Human Genome Patentable Subject Matter?
IDEA,
Journal of Law and Technology, 35(4):461-496 (1995).
Borson, D.B. Health
Care: The Big Picture. USF Forum
(Oct 24 1994).
Borson, D.B. Extended Parentship Act. Model Statute In: Adrienne D. Davis,
Symposium: Surrogacy Legislation in California; USF
Law Rev.
28(3):
582 - 588 (Spring 1994).
Borson, D.B., Reform of Compassionate Use of
Therapeutic Drugs. In: Daily
Wong, M., and Recorder (San Francisco) (May 5
1993).
Carriere, D.
INSTRUCTIONAL ACTIVITIES
Law and Intellectual Property
2018 Develop Guest Lecture on Entrepreneurship and
Intellectual Property, St. Mary’s College of California Entrepreneurship Program.
2016 Understanding
Patents in Mass Spectrometry. Develop and deliver workshop to members of
the Mass Spectrometry Applications for the Clinical Laboratory (MSACL) annual
Convention.
2014 Update on
Patents and Trademarks, Staff Research Conference, Pacific Edge Limited.
2014 Mass Spectrometry Applications in the Life
Sciences: develop and deliver lectures on commercialization and intellectual
property.
2013-14 Society for Brain Mapping and
Therapeutics: develop and deliver lectures on commercialization and
intellectual property.
2009-2015 Contra Costa County Bar Association,
Business Law Corporate Counsel Section: develop, organize and deliver lectures
in business and IP law.
2011-2014 Australian Biotechnology Organization
(AusBiotech): develop and
present lectures on commercialization and
international IP law.
2010-2015 Golden Gate University School of Law
Adjunct
Professor of Law, Course Director and lecturer:
Biotechnology
Law,
Patent Law
2009-2013 New Zealand Biotechnology Organization
(NZBIO): develop and
present lectures on International IP law and
commercialization.
2006- Borson Law Group, PC: develop and
present workshops and lectures on
intellectual
property protection, scientific processes, commercialization,
and
defense for clients.
2001- State
Bar of California
Intellectual Property Section Representative to the
Conference of
Delegates of California Bar Associations: Coordinate
and implement
activities of the Council of State Bar Sections. Develop
and implement
strategies for statewide continuing legal education.
Lectures
for State Bar Annual Meeting, 2001-2008
Lectures
for State Bar IP Section Annual Institute
Lecture
for State Bar of
Chair,
Planning Committee for U.S.P.T.O. Symposia, 2003, 2005
Lecturer, State Bar Annual Meeting, 2003-2006:
Overview of IP and
Ethics
in IP Practice.
Lecturer, Intellectual Property Institute, 2002 -
2006. Delivered lectures on
Claim
Drafting, Law and Equity in IP, Ethics in IP Practice and IP
overview
Member, Planning Committee for the Business
Law/Intellectual Property
Law
Section Third Annual Joint Meeting, La Costa Resort, 2002.
Prepared and delivered lectures on Patent Claiming
Strategies, Business
Aspects
of IP law, Legal Ethics in Intellectual Property Practice,
Doctrine
of Equivalents and Law & Equity
Member,
Planning Committee for Copyright Office Comes to
Author,
articles relating to intellectual property
2002 - 2011 BioScience Forum, non-profit,
educational corporation for Life Science professionals: Founder and President:
Formerly Northern California Pharmaceutical Discussion Group. Organize and moderate lectures, panel
discussions and symposia relating to life sciences, regulatory affairs and
legal affairs for scientists, entrepreneurs and professional personnel. Prepare
and present lectures on IP law to life scientists.
1997 - 2006 Fliesler Meyer LLP (Formerly Fliesler,
Dubb, Meyer & Lovejoy LLP)
Develop
and implement strategies for teaching attorneys intellectual
property
law
Prepare
and deliver IP lectures to Attorneys and Staff.
Develop and present lectures
relating to Patent Office procedures and case law
Prepare and deliver lectures to universities,
businesses and professional
organizations
relating to discovery inventions, intellectual
property,
life sciences, chemistry and biotechnology
1997 - 2002 Northern
California Pharmaceutical Discussion Group
Non-profit
educational organization (became BioScience Forum).
Organize and moderate lectures in Life Sciences for
business and
professional
personnel. Prepare and deliver lectures relating to
intellectual
property law.
LEGAL PRESENTATIONS
Entrepreneurship and Intellectual Property, St. Mary’s College of
California Guest
Lecture. 26 November 2018.
Patent Eligible Subject
Matter, Obviousness, and Obviousness-Type Double Patenting
Contra Costa County Bar
Association, Intellectual Property Law Section Conference.
April 17, 2018.
Two Entrepreneurs Walk Into a Bar to Mull Over Purchase Offer, Contra Costa County Bar
Association CLE Spectacular, November 18, 2016.
Understanding Patents in Mass Spectrometry, Workshop presented to the Annual Convention of the
Mass Spectrometry Applications for Clinical Laboratories (MSACL), Palm Springs, CA February
23, 2016.
Two Entrepreneurs Walk Out of a Bar: Panel Discussion on the Legal Issues
Faced by Businesses. Contra Costa County Bar Association CLE Spectacular, November 20,
2015.
Two Entrepreneurs Walk Out of a Bar: Panel
Discussion on the Legal Issues Faced by Businesses. John F. Kennedy University
Entrepreneurs October 22, 2015.
Patent Law of the United States: Course Director and Lecturer: Golden
Gate
University School of Law, (August – November 2015).
Creating Win-Win Scenarios Between Australia and China: Lecture and Panel:
AusbioTech Invest Conference, Melbourne Australia (2-3
December 2014).
Patent Law of the United States. Course
Director and Lecturer: Golden Gate
University School of Law, (August – November 2014).
Two Entrepreneurs Walk into a Bar, Presentation for the John F. Kennedy University
Innovation Cluster, (June 11, 2014).
Recent Foreign Patent Legislation and USPTO Rulemaking, Patent Interest Group
Teleconference, IP Law Section, State Bar of
California,
(April 10, 2014).
Translational Medicine, Education, Policy, Commercial and IPIssues, Keynote Speaker:
Society for Brain Mapping and Therapeutics, 11th Annual
Convention, Sydney,
Australia, (18 March 2014).
Commercialization and Protection of Intellectual Assets in Application to
Mass
Spectrometry,Plenary Lecturer: Mass Spectrometry Applications in Clinical
Laboratory, Annual Convention, (March 2, 2014).
Multijurisdictional Ethics: Review of California and USPTO Rules of
Professional Responsibility; State Bar of California Intellectual Property Law
Institute, (November 8, 2013).
Patent Law of the United States. Course Director and Lecturer: Golden
Gate
University School of Law, (August – November 2013).
Bringing Inventions to the Wider World: Protection Strategies and
Commercialization; Invited Speaker, Society for Brain Mapping and Therapeutics
10th World Conference on Brian Mapping (May 14, 2013).
Biotechnology Law, Course Director and Lecturer: Golden Gate University School
of Law, (January – May 2013).
Using Intangible Assets in Starting and Running a Business. Business Law Corporate
Counsel Section, Contra Costa County Bar Association, (April 24,
2013).
Patent Law of the United States. Course Director and Lecturer: Golden Gate
University School of Law, (August – November 2012).
Getting Started in Business: How to Advise Start-Up Enterprises. With Peter Sproul,
Contra Costa County Bar Association Business Law
Corporate Counsel Section,
(July 18, 2012).
New United States Patent Laws and Implications for New Zealand
Biotechnology,
Speaker, Organizer and Chair, NZBIO Convention Auckland, New Zealand, (March
26, 2012):
How to Fire your Bad Clients and Keep the Good Ones. Business Law Corporate
Counsel Section, Contra Costa County Bar Association
Intellectual Property: An Element of Success of a Technology Company’s
Life Cycle, Australian
Biotechnology Organization Conference, Adelaide, Australia, (October 2011).
Workshops on the America Invents Act of 2011, International and Commercialization Strategies, Organizer and Speaker, NZBIO, Auckland & Dunedin New
Zealand, (October 2011).
The Leahy-Smith America Invents Act of 2011. Intellectual Property
Law Section Teleseminar, State Bar of California:
Copyright Threats to Companies With Web Designs, Business Law Corporate Counsel/Intellectual Property
Section presentation
with Stuart West, Contra Costa County Bar Association, (June 16, 2011).
Tips on Starting an IP Firm, State Bar of California IP Section
teleseminar, (May 24, 2011).
Biotechnology Law, Course Director and Lecturer: Golden Gate University School of
Law, (January – May 2011).
What Every Business Attorney Needs to Know About Intangible Assets. Business Law Corporate
Counsel Section, Contra Costa County Bar Association, (April 20, 2011).
Commercialization and Intellectual Property Strategies, NZBIO Conference, Auckland, New
Zealand, (March 23, 2011).
Workshops on International Intellectual Property and Commercialization Strategies, Organizer and Speaker: University of Otago and Otago
Innovation Ltd, Dunedin, New Zealand, (March 2011).
Update on Federal Legislation and USPTO Rulemaking. State Bar of California
Teleseminar, Cyberlaw program, (January 29, 2011).
Patenting and Patent Law from Legal and Technical Viewpoints, State Bar of California
Teleseminar, Cyberlaw program, (January 2011).
Creating a World-Wide Intellectual Property Strategy, NZBIO Annual Convention,
Auckland New Zealand, (March 18, 2010).
Section 101, Utility and Patentable Subject Matter in the Discovery Arts, USPTO Biotechnology, Chemical and Pharmaceutical
Partnership Meeting. (September 8,
2010).
International Intellectual Property Law, Acquisition, Exploitation
and Enforcement:
State Bar of
California Section Education Institute, (January 17, 2009).
California
and Federal Ethics in Intellectual Property Law, State Bar of
California
Annual
Meeting, (September 26, 2008).
Assisting
with U.S. Paten Prosecution, In: U.S. Patent Practice for Paralegals: HalfMoon
LLC. (June 26, 2008).
Intellectual Property
Basics for Non-Specialists State
Bar of California Section
Education Institute, (January 18, 2008).
New Patent
Legislation and PTO Rule Changes, State Bar of California Intellectual
Property
Institute, (November 10, 2007).
Ethics Issues
in Intellectual Property Practice, State
Bar of California Annual Meeting, (September
28, 2007).
Discovery Inventions: UCSF Entrepreneur Camp, (July 30, 2007).
Law of
Obviousness in Light of KSR, Pfizer
and Takeda: Possible Patent Strategies,
Silicon Valley Intellectual Property Law Association, (September
13, 2007).
New Legislation and Case Law: State Bar of California Intellectual Property Annual
Institute, (November 2007).
International Law Weekend West. Santa Clara University School of Law, Santa
Clara,
California, (February 2-3, 2007).
Patent
Practice Nuts and Bolds of Intellectual
Property, State Bar of California
Intellectual
Property Section Institute, (November
2006).
Continuing
Applications, Fliesler Meyer LLP Training Meeting, November 1, 2006.
Ethics and Multijurisdictional Intellectual Property
Practice, State Bar of California
Annual
Meeting, (October 5, 2006).
Patent
Practice: Current Strategies and Future Trends, San Diego
Intellectual Property
Law
Association, (June 22, 2006).
International Intellectual Property Protection:
Comparisons of U.S. and Foreign
Practice Issues for the General Practitioner, State Bar of
California Annual Meeting,
(October 2006).
Technology Transfer Systems and Intellectual Property
Protection. Osaka
University
Institute of
Scientific and Industrial Research,
Osaka, Japan.
Litigation and Arbitration: Fliesler
Meyer LLP, (2006).
Careers in
Science: IP Management and Technology Transfer, Stanford University, (November 7, 2005).
Resolution of Patentability Disputes in Europe. UCLA Symposium on International IP Practice,
(September 16, 2005).
Multijurisdictional Ethics: California and Federal
Law: State Bar of California Annual
Meeting, (September 11, 2005).
Patent Strategies for Follow-On Products.
on Global Follow-On
Biologics, Reston, VA, (December 6-7
2004).
Trust and Ethics in Intellectual Property Practice. State Bar of California Intellectual
Property
Section Annual Institute, (November
6, 2004).
Patents on
Discoveries in the Life Sciences, State Bar of California Intellectual
Property
Section Annual Institute, (November
5, 2004).
Intellectual
Property Rights Abroad: How to Obtain, Maintain and Defend Them, State
Bar of
California Annual Meeting, (October
9, 2004).
Ethics in IP and Corporate Matters. State Bar of California Intellectual
Property
Section
Annual Institute, (October 8, 2004).
Technology Transfer in the Life Sciences,
2004).
Intellectual
Property Strategies for Biotechnology Inventions, Haas Intellectual Property Workshop, Haas School of Business, UC Berkeley, (June
11, 2004).
Intellectual Property Ethical Issues for In-House
Counsel. State
Bar of California: In
House
Litigation Conference, (May 21, 2004).
IP Protection
& Provisional Pate4nts for Bio-related Inventions, UCSF
Entrepreneurs’
Discussion
Group, (November 19, 2003).
Post-Festo Update Law and Equity in Intellectual
Property, State Bar of California
Annual
Intellectual Property Institute, (November
8, 2003).
Intellectual
Property Strategies for Live Science Companies: Introduction to
Biotechnology
Patents, Course Director and Lecturer: IBC Life Sciences. (November
3-4, 2003).
Discovery
Inventions: Scientific and Legal Issues in Life Sciences Patents, Fliesler Meyer LLP (formerly Fliesler Dubb Meyer & Lovejoy LLP), 2003)
Whose Invention is it?
University of California, San Francisco, Innovation
Accelerator. (2003).
Ethics in Intellectual Property Law practice. Organizer and
Moderator, State Bar of
California
76th Annual Meeting, (September 4,
2003).
Current Status of U.S. Patent Law. Half
Moon Seminars, LLC, Eau Claire, WI, (June
17, 2003).
Protection of Discovery Inventions in the Life
Sciences, BioScience Forum, Milbrae, California (June 18, 2003).
IP Strategies and Implications in the Life Sciences, In: Symposium:
Defining and
Defending
Intellectual Property Rights in Biotechnology.J. Thomas McCarthy Institute
of IP and
Technology Law University of San
Francisco School of Law, (March 22,
2003).
Intellectual Property Issues in Medical Devices. Drug Information Agency, (February
24-26, 2003).
Doctrine of Equivalents in Light of Recent Case Law
Including Festo v. SMC Corp.: Law
and Equity in Intellectual Property. State Bar of
California Fall Intellectual Property
Institute, (November 9, 2002).
Ethics and Intellectual Property Practice. State Bar of
California Fall Intellectual
Property
Institute, (November 6-8, 2002).
Patent Claiming and Prosecution Strategies. Patent
Standing Committee, State Bar of
California
Intellectual Property Institute, (November
8, 2002).
Ethical
Considerations in IP Practice, FDML Staff Conference, (October 21, 2002).
Doctrine of
Equivalents in Light of Festo. v. SMC, J&J v. RES and Symbol Tech. v.
Lemelson: Law
and Equity in Intellectual Property, Intellectual Property Seminar
Series,
Fliesler, Dubb, Meyer & Lovejoy, LLP,
(June 27, 2002).
Ethics and Intellectual Property Practice. State Bar of California 3rd
Annual Spring Meeting, Business Law. Intellectual Property Joint Meeting, State Bar of California, (May 19, 2002).
European Patents, Intellectual Property Rights, Trade
Secrets, Trademarks and Branding
Issues, In:
Winning Strategies for Biomedical Companies in the European
Union,
World Trade
Organization of the Bay Area (2002).
Protecting Intellectual Property in High Technology:
Trade Secrets, Patents and Ethics,
State Bar of
California Annual Meeting, (September
7, 2001).
Preparing a Patent Application for Issuance, Half-Moon
Seminars for Paralegals, (June
13, 2001).
Doctrine of Equivalents in Light of Festo v. Shoketsu
Kinzoku Kogyo Kabushiki Co. and
SMC Pneumatics, Inc. Fliesler Dubb Meyer & Lovejoy LLP Attorneys’ Meeting,
(March 1, 2001).
Patent Law, Biotechnology and
Intellectual
Property Law Association, (February
22, 2001).
Current Issues in Biotechnology Patents: Hastings
School of Law: Intellectual
Property
Organization, (February 21, 2001).
Protecting Inventions in Combinatorial Chemistry, Keynote
Address: Cambridge
Healthtech
Conference: Eighth Annual Exploiting Molecular Diversity: Refining
Small
Molecule Libraries, (February 13,
2001).
Filing Patent Applications. Fliesler Dubb
Meyer & Lovejoy LLP Staff
Conference,
(January 24, 2001).
Patenting Biotechnological and Pharmaceutical
Inventions, Northern California Pharmaceutical Discussion Group, (December 13,
2000).
State Immunity from Federal Patent and Trademark Laws: California State Bar Association, IP Law
Section, Patent Standing Committee teleconference, (2000).
State Immunity from Federal Patent and Trademark Laws: Fliesler,
Dubb, Meyer &
Lovejoy Continuing
Legal Education Program, (June 23, 1999).
Overview of Intellectual Property International Patent
Practice, Half-Moon
Seminars,
Inc.
Changes to United States Patent Rules. Fliesler,
Dubb, Meyer & Lovejoy Continuing
Legal Education Program, (1997).
Uses of
Legal Education Program,
(1994).
SYMPOSIA ORGANIZED
USPTO Comes to California, Intellectual
Property Law Section of the State Bar of California, Los Angeles and San
Francisco, California (May 12, 14, 2010).
United States Patent and Trademark Office TC 1600 West Coast Road Show
2010, Organizer and Moderator, BioScience Forum, Millbrae, California, (February 24, 2010).
United States
Patent and Trademark Office TC 1600 West Coast Road Show 2008,
Organizer and
Moderator, BioScience Forum, Millbrae, California (November 12,
2008).
United States
Patent and Trademark Office TC 1600 West Coast Road Show 2007,
Organizer and
Moderator, BioScience Forum, Millbrae, California (October 31, 2007).
United States
Patent and Trademark Office TC 1600 West Coast Road Show 2005, Organizer and
Moderator, BioScience Forum, Millbrae, California (October 18, 2005).
Pain:
Mechanisms and Therapeutics, Organizer and Moderator, BioScience Forum,
Millbrae, California, (November 19, 2004).
Hot Topics in
Biotechnology Patent Law: USPTO Technology Center 1600, BioScience
Forum, Millbrae California, (September 9, 2004).
Application
of Biomarkers to the Drug Discovery and Development Process, Organizer
and
Moderator, BioScience Forum, Millbrae, California (June 25, 2004).
Clinical
Trials Symposium: The Impact of Regulatory Changes on Strategic Planning for
Clinical
Trials, BioScience Forum, San Mateo, (8 January 2003).
Current
Topics in Protein and Drug Binding: Conceptual, Clinical and Regulatory Issues,
Organizer and Moderator, BioScience Forum, Millbrae, California
(May 9, 2002).
United States
Patent and Trademark Office Symposium:
Hot Topics in Biotechnology &
Software Patents and New Legislation, Organizer and
Moderator, Northern California
Pharmaceutical
Discussion Group, Millbrae,
California (September 20, 2000).
EMPLOYMENT IN SCIENCE
1976 - 1992 University
of
Developer and lecturer, cardiovascular, pulmonary,
gastrointestinal and
renal
physiology
Developer and lecturer: National Board Review Program
in Physiology
and
Biochemistry,
Combined
lecture/laboratory program in
Physiology: Physical Therapy
Program
Designed courses, prepared course materials, prepared
and delivered
lectures,
wrote and evaluated examinations, supervised student
laboratories,
individual tutorials
Cardiovascular
Research Institute University of California San
Francisco:
Prepared and delivered numerous lectures relating to
scientific research at
University,
National and International meetings
Taught and supervised staff and post-doctoral fellows
relating to scientific
investigations
in neuroscience, physiology, molecular biology,
biochemistry
and pharmacology.
Supervised post-doctoral fellows in scientific writing
for publications
Mentored
post-doctoral fellows in drafting research grants
1986-1992 Adjunct
Lecturer, Department of Physiology, UCSF
1986-1992 Assistant
Research Physiologist, Cardiovascular Research Institute,
UCSF
1983-1986 Post
Doctoral Fellow, Cardiovascular Research Institute, UCSF
EMPLOYMENT IN OTHER DISCIPLINES
1969 - 1977 Federal
Aviation Administration Certified Flight Instructor, Airplane and Instrument;
Ground Instructor: Airplane,
Private, Commercial, Instrument and Multi-engine pilot ratings. President and Chief Pilot, Buchanan Flying
Club
1960- Concert flutist
Performances
of Baroque, Classical, Romantic, Modern, and Avant Garde music, orchestral,
chamber works, and solo performances.
1960 - 1968 Flute
Instructor
Instructed
private students and master classes, President, Bay Flute Club
HONORS AND AWARDS
2018- Lifetime Achievement Award, Marquis
Who’s Who.
2018- Intellectual Property Law Achievement Award,
Marquis Who’s Who.
2018- President of the Board of Directors,
Contra Costa Performing Arts
Society.
2015- Member of the Board of Directors,
Contra Costa Performing Arts
Society
2014-2018 President, Amphion Music Club.
2014- Member
of the Board of Directors, Amphion Music Club
2014 Member, Committee on Professional
Responsibility and Conduct,
State
Bar of California
2010- Adjunct Professor of Law, Golden Gate
University School of Law.
2014-2016 Treasurer, Business Law Corporate
Counsel Section, Contra Costa
County
Bar Association.
2014- Co-Chair, AIPLA Patent Law Committee,
Subcommittee on Patent
Policy.
2010-2013 Chair, Business Law Corporate Counsel
Section, Contra Costa County
Bar
Association.
2009-2012 Member, Patent Public Advisory Committee,
USPTO
2009-2011 Co-Chair, AIPLA Subcommittee on Section
101, Patent Committee
2011-2013 Co-Chair, AIPLA Patent Law Subcommittee
on Patentability.
2009-2011 Delegate from IP Section of California
State Bar to the Conference of
2007-2009 Delegate from IP Section of California
State Bar: Conference of Delegates
of
2006- Chair, Intellectual Property Law
Section Legislation Interest Group
2004-2006 Member, Board of Governor’s Task Force on
Sections, State Bar of
2004-2008 Advisor, Intellectual Property Law
Section, State Bar of
2006- Member, IP Law Section and
International Law Section, State Bar of
2004-2006 Chair, Intellectual Property Section
Commission on Proposed USPTO
Rules of Professional
Responsibility.
2003-2005 Co-Vice Chair (2003), Co-Chair
(2004-2005)
Council of State Bar of California Sections
2002-2009 Founder and President, BioScience Forum,
non-profit life sciences
educational
corporation
2002-2004 IP Section Representative: Council of
Sections: State Bar of California.
2001-2004 Member: Executive Committee: State Bar
of California Intellectual
Property Section
2001- Member: Intellectual Property Advisory
Committee:
Law
2000- 2002 Chair, Northern California
Pharmaceutical Discussion Group
1999 - Member, Patent Standing Committee,
State Bar of
1999-2000 Chair-Elect, Northern California
Pharmaceutical Discussion Group
1998-2000 Advisory Board, Board of Directors:
Pharmaceutical Discussion Group.
1994-1996 Board of Directors, Balboa Terrace
Homes Association
1991 Member, Special Review Committee, National
Institute of Health:
National Heart, Lung, and
1990 - Biography listed in:
Who’s
Who in the World
Who’s
Who in
Who’s
Who of American Attorneys
Who’s
Who in Science and Technology
Who’s
Who in Education
Who’s
Who in the West
1989-1994 NIH Program Project Grant: HL 24136
Project D7:
Modulation
of Airways by Neutral Endopeptidase
1988-1991 Cystic Fibrosis Research Development
Program Grant: RO 149-1
Neuropeptide
Release from Airways
1989 to 1992 Editorial Board, American Journal of
Physiology: Lung Cellular and
Molecular
Physiology
1987-1992 Principle Investigator, NIH First
Independent Research Service and
Transition
Award: HL-38947, Role of
Enkephalinase in
Regulating
Airways.
1987 Co-inventor: Therapeutic Use of
Enkephalinase
U.S.
Patent No. 5,262,178 issued 1993
U.S. Patent No.
5,403,585 issued 1995.
1986-1987 UCSF Academic Senate Committee on Research
Grant:
Regulation of Release
of Airway Glycocalyx by Proteinases
1985-1986 UCSF Research Education and Allocation
Committee Grant:
Effects
of Peptides and Proteinases on Airway Secretion.
1984-1989 NIH Program Project Grant: HL 24136:
Project D7:
Regulation
of Airway Secretion.
1984-1986 American Lung Association of
Roles
of Inflammatory Peptides in Regulating Mucus Secretion
1984 - 1986 Parker B. Francis Research Fellowship
1984 Cystic Fibrosis Research Fellowship
1983 - 1984 United States Public Health Service
Postdoctoral Fellowship
1976 - 1982 United States Public Health Service
Predoctoral Traineeship
SCIENTIFIC EXPERIENCE
1990 - 1992 GENENTECH, INC.,
Genetics: Visiting Scientist.
Original Scientific Research
Designed and carried out studies in biochemistry,
molecular biology, gene expression, cell culture, cellular transformation &
mutagenesis of a mammalian cell surface enzyme with therapeutic utility.
1986 - 1992 UNIVERSITY OF
Cardiovascular
Research Institute, Assistant
Research Physiologist
Original Scientific Research:
Ran biomedical research laboratory, Trained Staff and supervised post-doctoral
fellows.
Physiology and Pharmacology, Designed and carried out physiological and
pharmacological
studies on glycoprotein secretion, regulation of muscle
action,
reflexes interaction of different branches of the nervous system,
hormonal
regulation in vivo and in vitro.
Biochemistry:
Designed and carried out biochemical studies of peptide
degradation,
enzyme purification, neurotransmitter release, and macro
molecular
secretion.
Molecular Biology and Genetics: Designed and
carried out molecular biological
studies
on gene transcription, translation, and product translation of
endogeneous
and exogeneous genes in tissues and cell culture.
Wrote and administered research
grants
Authored
over 80 publications in mammalian physiology, biochemistry, and
molecular
biology relating to neural and humoral regulation of
mammalian
organ systems
Inventor Therapeutic Use of Enkephalinase.
Two Issued Patents
Teacher Physiology, cell biology, biochemistry,
molecular biology, scientific
research
methods, scientific writing
Service to Scientific Community: Reviewed
manuscripts and grants. Presented
lectures
and seminars, and chaired scientific meetings.
1986 - 1992 UNIVERSITY
OF
Department of Physiology, Adjunct
Lecturer
Lectures
and Laboratories: Physiology, pharmacology and biochemistry
for
students in Medical, Pharmacy, Dentistry and Physical Therapy
programs.
1983 - 1986 UNIVERSITY
OF CALIFORNIA, SAN FRANCISCO
Cardiovascular
Research Institute, Postdoctoral Fellow
Original
Scientific Research:
Neural
and humoral regulation of the respiratory system
1976-1983 UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Department
of Phisiology, Graduate Student
Ph.D. Dissertation: Neural Regulation of Secretion from Tracheal
Submucosal
Glands (1983)
SELECTED INVITED SCIENTIFIC LECTURES
1983 National
Institutes of Health, Clinical Staff Conference
Neurohumoral
Regulation of Airway Secretion
1983
Inflammatory
Regulation of Airway Secretion
1984, 1986 Vicks
Division of Research: Conference on Respitory Secretions
Neurohumoral
Regulation of Airway Secretion
1988 Transatlantic
Airways Conference,
Roles
of Neutral Endopeptidase in Regulating Airways
1988
Roles
of Peptides and Proteinases in Regulating Airway Functions
1988 International
Conference on Rhinitis and Asthma,
Airway
Secretions.
1988 Third
Annual Conference on Clinical Immunology, San Francisco
Neuropeptides
and the Lung: Animal Models and Human Disease
1988 UCSF
Quality Assurance and Clinical Conference; Adult Allergy Faculty Practice; Neuropeptides
and Lung Reactions.
1989 Temple
University Pulmonary Division; Conference on Proteases in Disease: Role of Neutral Endopeptidase in Airways
1989
Roles of Neutral Endopeptidase in Regulating
Peptide-Induced Phenomena
1989 Temple
University Department of Physiology
Role
of Neutral Endopeptidase in Regulating Peptide-Induced Responses
1990 XIII
International Congress of Asthmology
Neutral
Endopeptidase as a Possible Anti-inflammatory Drug
1990
Roles,
Regulation, and Therapeutic Potential of Neutral Endopeptidase
1990 Women’s
1991
Roles
and Regulation of Neutral Endopeptidase
SELECTED SCIENTIFIC PUBLICATIONS
Peer-Reviewed Articles
1. Borson
DB, Chinn RA, Davis B, Nadel JA. Adrenergic and cholinergic nerves mediate
fluid secretion from tracheal glands of ferrets. J
Appl Physiol 49:1027-1031,
1980.
2. Borson
DB, Charlin M, Gold BD, Nadel JA. Neural regulation of 35SO4-macromolecule
secretion from tracheal glands of ferrets. J Appl Physiol 57:457-466, 1984.
3. Gashi
AA, Borson DB, Finkbeiner WE, Nadel JA, Basbaum CB. Neuropeptides
degranulate serous cells of ferret tracheal glands. Am
J Physiol 251(Cell Physiol 20):C223-C229,
1986.
4. Borson
DB, Corrales R, Varsano S, Gold M, Viro N, Caughey G, Ramachandran J, Nadel
JA. Enkephalinase
inhibitors potentiate substance P-induced secretion of 35SO4-macromolecules
from ferret trachea. Exp
Lung Res 12:21-36, 1987.
5. Caughey
GH, Viro NF, Ramachandran J, Lazarus SC, Borson DB, Nadel JA. Dog
mastocytoma tryptase: affinity purification, characterization and
amino-terminal sequence. Arch
Biochem Biophys 258:555-563, 1987.
6. Sekizawa K, Tamaoki J, Nadel JA, Borson DB. Enkephalinase inhibitor potentiates substance P- and
electrically induced contraction in ferret trachea. J Appl Physiol 63:1401-1405,
1987.
7. Varsano
S, Basbaum CB, Forsberg LS, Borson DB, Caughey G, Nadel JA. Dog
tracheal epithelial cells in culture synthesize sulfated macromolecular
glycoconjugates and release them from the cell surface upon exposure to
extracellular proteinases. Exp Lung Res 13:157-183, 1987.
8. Dusser
DJ, Nadel JA, Sekizawa K, Graf PD, Borson DB.
Neutral endopeptidase and
angiotensin converting enzyme inhibitors potentiate kinin-induced contraction
of ferret trachea. J Pharm Exp Ther 244:531-536,
1988.
9. Sheppard
D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DB. Toluene
diisocyanate increases airway responsiveness to substance P and decreases
airway enkephalinase. J Clin
Invest 81:1111-1115, 1988.
10. Dusser
DJ, Umeno E, Graf PD, Borson DB, Nadel JA.
Airway neutral endopeptidase-like
enzyme modulates tachykinin-induced bronchoconstriction in vivo. J
Appl Physiol. 65:2585-2591, 1988.
11. Kohrogi
H, Graf PD, Sekizawa K, Borson DB, Nadel JA.
Neutral endopeptidase inhibitors
potentiate substance P- and capsaicin-induced cough in awake guinea pigs. J Clin Invest 82:2063-2068, 1988.
12. Djokic TD, Sekizawa K, Borson DB, Nadel
JA. Neutral endopeptidase inhibitors
potentiate substance P-induced contraction in gut smooth muscle. Am J Physiol 256:G39-G41, 1989.
13. Djokic
TD, Nadel JA, Dusser DJ, Sekizawa K, Graf PD, Borson DB. Inhibitors
of neutral endopeptidase potentiate electrically and capsaicin-induced
noncholinergic contraction in guinea pig bronchi. J
Pharmacol Exp Ther 248:7-11, 1989.
14. Borson
DB, Brokaw JJ, Sekizawa K, McDonald DM, Nadel JA. Neutral
endopeptidase and neurogenic inflammation in rats with respiratory infections. J
Appl Physiol. 66:2653-2658, 1989.
15. Kohrogi
H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh B, Patton JS, Borson DB. Recombinant
human enkephalinase (neutral endopeptidase) prevents cough induced by
tachykinins in awake guinea pigs. J
Clin Invest 84:781-786, 1989.
16. Dusser DJ, Djokic TD, Borson DB, Nadel
JA. Cigarette smoke induces
bronchoconstrictor hyperresponsiviness to substance P and inactivates airway
neutral endopeptidase in the guinea pig. J
Clin Invest, 84:900-906, 1989.
17. Rubinstein I, Iwamoto I, Ueki IF, Borson
DB, Nadel JA. Recombinant
neutral endopeptidase attenuates substance P-induced plasma extravasation in
the guinea pig skin. Int Arch Allergy and Appl Immunol. 91:232-238, 1990.
18. Borson
DB,
19. Katayama
M, Nadel, J.A, Bunnett NW, DiMaria, G.U, Haxhiu, M.A., Borson DB. Catabolism
of calcitonin gene-related peptide by neutral endopeptidase. Peptides
12:563-567, 1991.
20. DiMaria GU, Katayama M, Borson DB, and
Nadel JA. Neutral endopeptidase modulates
endothelin-1-induced airway smooth muscle contraction in guinea pig.
Regul. Peptides 39:137-145, 1992.
Review Articles, Books, and Book Chapters
21. Borson,
DB. Neural regulation of secretion from tracheal submucosal glands.
Ph.D.
Dissertation.
22. Nadel JA, Borson DB, Basbaum DB,
Widdicombe JH. Techniques
for studying airway mucus secretion, ion transport and water movement. In Techniques in the Life
Sciences. Techniques in Respiratory Physiology - Part I. Otis AB,
ed. Elsevier Scientific Publishers
Ireland Ltd.,
23. Nadel
JA, Borson DB. Secretion and ion transport in airways during inflammation. Biorheology
24:541-549, 1987.
24. Nadel
JA, Borson DB. Modulation of neuropeptide actions by enkephalinase. In Pharmacology. Rand MJ, Raper
C, eds. Elsevier Science Publishers
B.V., pp: 425-439, 1987.
25. Nadel
JA, Borson DB. Modulation of tachykinins and bradykinin by enkephalinase. In Mechanisms
in Asthma: Pharmacology, Physiology, and
Management. Armour CL, Black JL,
eds. Alan R. Liss, Inc.
26. Borson
DB, Gashi AA, Nadel JA. Methods for studying secretion from airways. In: Methods in Mucology.
27. Borson
DB, Nadel JA. Regulation of airway secretions.
In Workshop on Rhinitis
and Asthma; Similarities and Differences.
Mygind N, Pipkorn U, Dahl R, eds. Munksgaard, Copehnagen, Denmark,
Chapter 6, pp:76-99, 1990.
28. Borson
DB. Roles
of neutral endopeptidase in airways. Am. J. Physiol. 260 (Lung Cellular and Molecular Physiol.
4:L212-L225, 1991.
29. Borson,
DB, Nadel, JA. Neutral Endopeptidase as a Possible Therapeutic Drug. In: Advances in Asthmology 1990:
Proceedings of the XIII International Congress of Asthmology, held in
30. Borson,
DB. Possible
Roles of Peptides and Peptidases in Asthma.
American
Abstracts
31. Gamsu G, Borson B, Webb WR, Nadel
JA. Structure: function correlation in
tracheal stenosis. Am
Rev Respir Dis 115:328, 1977.
32. Borson
B, Chinn R, Davis B, Nadel J. Electrical stimulation of cholinergic nerves
to submucosal glands in ferret trachea in vitro. Physiologist
22:12, 1979.
33. Borson
DB, Nadel J. Mucous secretory response of canine tracheal pouch. Fed
Proc 38:1330, 1979.
34. Borson
DB, Nadel JA. Adrenergic neurotransmission to tracheal submucosal glands of ferrets. Clin
Res 29:98A, 1981.
35. Borson
DB, Nadel JA. Cholinergic nerves inhibit adrenergic neurotransmission to tracheal
submucosal glands of ferrets. Fed Proc 40:254, 1981.
36. Borson
DB, Charlin M, Gold BD, Nadel JA. Nonadrenergic noncholinergic nerves mediate
secretion of macromolecules by tracheal glands of ferrets. Fed
Proc 41:1754, 1982.
37. Borson
DB, Caughey G,
38. Borson
DB, Corrales RJ, Viro N, Nadel JA. Substance P (SP) regulation of 35SO4
macromolecule secretion from ferret trachea. Am Rev Respir Dis 131:A27, 1985.
39. Borson
DB, Gold M, Varsano S, Caughey G, Ramachandran J, Nadel JA. Enkephalinase
inhibitors potentiate tachykinin-induced release of 35SO4-labeled
macromolecules from ferret trachea. Fed Proc 45:626, 1986.
40. Borson
DB, Malfroy B, Gold M, Ramachandran J, Nadel JA. Tachykinins
inhibit enkephalinase activity from tracheas and lungs of ferrets. Physiologist
29:174, 1986.
41. Forsberg LS, Varsano S, Borson DB,
Basbaum CB, Nadel JA. Keratinase-sensitive
cell surface glycans are synthesized by cultured tracheal epithelial cells. Fed
Proc
45:1904, 1986.
42. Sekizawa K, Tamaoki J, Nadel JA, Borson
DB. Enkephalinase inhibitor
(leucine-thiorphan) potentiates mammalian tachykinin-induced contraction in
ferret trachea. Fed Proc 46:650, 1987.
43. Sheppard D, Thompson JE, Scypinski L,
Dusser D, Nadel JA, Borson DB. Toluene
diisocyanate increases airway responsiveness to substance P and decreases
airway enkephalinase. Physiologist
30:196, 1987.
44. Borson
DB, Brokaw J, Sekizawa K, McDonald D, Nadel JA.
Viral infection increases
permeability response to substance P (SP) by decreasing tracheal neutral
endopeptidase (NEP). FASEB J. 2:A1382, 1988.
45. Borson
DB, Brokaw J, Sekizawa K, McDonald D, Nadel JA.
Viral infection increases tracheal
permeability response to substance P (SP) in rats by decreasing neutral
endopeptidase (NEP). J Cell Biochem [Suppl] 12B:295,
1988.
46. Nadel
JA, Djokic TD, Djokic LT, Borson DB. Neutral endopeptidase inhibitor potentiates
neurotensin-induced contraction in guinea pig bronchi. FASEB
J. 2:A1383, 1988.
47. Kohrogi H, Nadel JA, Malfroy B, Gorman C,
Bridenbaugh B, Patton JS, Borson DB. Recombinant
enkephalinase inhibits substance P- and capsaicin-induced cough in awake guinea
pigs.
Am Rev Respir Dis
139:A133, 1989.
48. Borson
DB, Jew S, Gruenert DC. Glucocorticoids increase expression of
neutral endopeptidase in transformed human tracheal epithelial cells. Physiologist 32:226, 1989.
49. Katayama M, Bunnett NW, Ueki IF, Nadel
JA, Borson DB. Recombinant
human neutral endopeptidase (NEP) cleaves calcitonin gene-related peptide
(CGRP). FASEB J. 4:A998, 1990.
50. DiMaria GU, Katayama M, Graf PD, Borson
DB, Nadel JA. Neutral
endopeptidase modulates endothelin-induced contraction of guinea pig trachea. Pharm. Res. 22 (Suppl2):170,
1990.
51. Borson
DB,
52. Borson
DB, Katayama M. Calcitonin gene-related peptide inhibits cleavage of substance P by
recombinant human neutral endopeptidase.
FASEB J.5:A863,
1991.
53. Katayama
M, Nadel JA, Borson DB. Recombinant
human neutral endopeptidase (NEP) cleaves human endothelin (ET1). FASEB J.
5:A863, 1991.
54. Borson DB, Gies D, and C. Gorman. Transmembrane
domain is necessary for expression of
functional human neutral endopeptidase.
J. Cell. Biol.
115:61A, 1991.